Japan’s Matsushita To Market New Drug-Discovery System Soon
This article was originally published in PharmAsia News
Executive Summary
Matsushita Electric Industrial plans to develop a new drug-discovery system in conjunction with Kalapsys and market it in North America and Europe. The system, commercialized by Matsushita subsidiary Panasonic Factory Solutions is capable of processing more than 1,500 compounds in a minute and is said to be easily expandable to add other functions, such as transfering compounds or mixing proteins. Matsushita and Kalypsys, a Novartis spinoff, plan to market the system in North America within a few months, with an aim for the top market share by 2010. (Click here for more - a subscription may be required
|
Matsushita Electric Industrial plans to develop a new drug-discovery system in conjunction with Kalapsys and market it in North America and Europe. The system, commercialized by Matsushita subsidiary Panasonic Factory Solutions is capable of processing more than 1,500 compounds in a minute and is said to be easily expandable to add other functions, such as transfering compounds or mixing proteins. Matsushita and Kalypsys, a Novartis spinoff, plan to market the system in North America within a few months, with an aim for the top market share by 2010. (Click here for more - a subscription may be required) "Matsushita To Market Drug Discovery System Globally" - Nikkei (Japan) (4/8/08) |